======= KCNQ4 ======= == Gene Information == * **Official Symbol**: KCNQ4 * **Official Name**: potassium voltage-gated channel subfamily Q member 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9132|9132]] * **UniProt**: [[https://www.uniprot.org/uniprot/P56696|P56696]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KCNQ4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KCNQ4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603537|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene forms a potassium channel that is thought to play a critical role in the regulation of neuronal excitability, particularly in sensory cells of the cochlea. The current generated by this channel is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. The encoded protein can form a homomultimeric potassium channel or possibly a heteromultimeric channel in association with the protein encoded by the KCNQ3 gene. Defects in this gene are a cause of nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Probably important in the regulation of neuronal excitability. May underlie a potassium current involved in regulating the excitability of sensory cells of the cochlea. KCNQ4 channels are blocked by linopirdin, XE991 and bepridil, whereas clofilium is without significant effect. Muscarinic agonist oxotremorine-M strongly suppress KCNQ4 current in CHO cells in which cloned KCNQ4 channels were coexpressed with M1 muscarinic receptors. |KCNQ channel| |Ion trans 2| |Ion trans| |potassium channel activity| |delayed rectifier potassium channel activity| |basal plasma membrane| |voltage-gated potassium channel activity| |voltage-gated potassium channel complex| |inner ear morphogenesis| |ear morphogenesis| |sensory perception of sound| |potassium ion transmembrane transport| |sensory perception of mechanical stimulus| |potassium ion transport| |inner ear development| |calmodulin binding| |ear development| |sensory organ morphogenesis| |embryonic organ morphogenesis| |monovalent inorganic cation transport| |embryonic organ development| |regulation of ion transmembrane transport| |sensory organ development| |inorganic cation transmembrane transport| |regulation of transmembrane transport| |embryonic morphogenesis| |cation transmembrane transport| |metal ion transport| |inorganic ion transmembrane transport| |regulation of ion transport| |cation transport| |ion transmembrane transport| |animal organ morphogenesis| |sensory perception| |embryo development| |transmembrane transport| |ion transport| |nervous system process| |regulation of transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.7| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.75| |[[:results:exp494|Isoniazid 100μM R08 exp494]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3720 * **Expression level (log2 read counts)**: -1.53 {{:chemogenomics:nalm6 dist.png?nolink |}}